Tonix Pharmaceuticals Holding Corp

Tonix Executives Buy Zero‑Cost Options, Signaling Confidence in CNS Pipeline & FDA Progress

Tonix insider option purchases signal confidence as CNS drug pipeline—TNX‑102 & TNX‑201—faces FDA review; investors should track clinical milestones and regulatory decisions for potential upside.

Tonix Pharmaceuticals Holding Corp
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

26/02/2026, 13:19

3 minutes to read